Has Neill Peters, MD received payments from drug or device companies?

Yes. Drug and device makers reported $114,753 in general payments to Neill Peters, MD across 394 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Neill Peters, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Neill Peters, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Neill Peters, MD

Dermatology · Chicago, ILNPI 1215912795

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $82,822 of the $114,753 with a category attached, or 72.2%. 17 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 46.0% of the total. Reporting peaked in 2023 at $48,600 and has fallen 50.3% since, to $24,135 in 2025. Among dermatology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$114,753in general payments, 2019–2025

Across 394 payments — averaging $291.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$53K
Sanofi$42K
Arcutis Biotherapeutics, Inc.$16K
Johnson & Johnson$1K
AbbVie$912
Amgen$501
plus $1K from 11 others

What the payments were for

Consulting fees$13,07511%
Speaking & faculty fees$82,82272%
Travel & lodging$10,94210%
Food & beverage$7,6207%
Education$2930%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	80	$52,778
Sanofi	30	$42,453
Arcutis Biotherapeutics, Inc.	55	$15,694
Johnson & Johnson	82	$1,193
AbbVie(2 entities)	60	$912
Amgen	21	$501
Galderma Laboratories, L.p.	22	$307
Lilly USA, LLC	12	$249
Pfizer	7	$173
Novartis	9	$167
LEO Pharma Inc.	4	$85
Sun Pharmaceutical Industries Inc.	3	$74
UCB, Inc.	2	$45
Dermavant Sciences, Inc.	2	$44
Taro Pharmaceuticals USA, Inc.	2	$31
Revance Therapeutics, Inc.	1	$25
Strata Skin Sciences, Inc.	2	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$93,753

How this compares

$114,753 in reported general payments places this provider in the 95th percentile of 606 dermatology providers in Illinois.

See all dermatology providers in Illinois →

Medicare billing

Part B allowed, 2024

$304,602

Medicare patients

1,131

Services billed

4,931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	22	$80,676
Dupixent SyringeDupilumab	16	$58,558
Halobetasol Propionate	57	$3,630
Metronidazole	43	$2,342
Acitretin	11	$2,221
Mometasone Furoate	128	$2,083
Betamethasone Dipropionate	71	$1,947
Ketoconazole	123	$1,831
Doxycycline Hyclate	63	$1,157
Fluorouracil	17	$973
Alclometasone Dipropionate	34	$901
Hydrocortisone	53	$789
Clindamycin Phosphate	26	$768
Minoxidil	80	$671
Fluocinonide	22	$590

Paid to pharmacies, not to this prescriber.

Other dermatology in Chicago

Raj ChovatiyaChicago$3.6M
Peter LioChicago$2.4M
Elizabeth KiracofeChicago$1.6M
Carolyn JacobChicago$566K
Walter LiszewskiChicago$414K
Omer IbrahimChicago$313K
Caroline RobinsonChicago$308K
Smita AggarwalChicago$214K
Tracee BlackburnChicago$180K
Faiyaaz KalimullahChicago$137K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →